OTC · Biotechnology

NDT Pharmaceuticals Inc. (NDTP) Stock

$0.55 -0.36% OTC: NDTP Healthcare

NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.

Valuation

MetricValue
Price$0.55
Market Cap$87.68M
P/E Ratio-421.54
P/B Ratio2.72
P/S Ratio716.71
EPS (TTM)$0.00
52-Week High$2.10
52-Week Low$0.05
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.08%
ROA-0.75%
ROCE-0.75%
Gross Margin-32.44%
Operating Margin-248.67%
Net Margin-251.62%
Debt/Equity0.02
Current Ratio4.09

Annual Financials (USD)

Metric20162017202320242025
Revenue$0$0$0$0$0
Operating Profit$0$0$0$0$0
Net Profit$0$0$0$0$0
EPS$-0.01$0.00$0.00$0.00$0.00
Op Margin—————

Balance Sheet (USD)

Metric20162017202320242025
Total Assets$0$0$0—$0
Total Liabilities$0$0$0—$0
Cash$0$0$0—$0
Borrowings$0$0$0$0$0

Latest News

Good Salt Life Expands Clean Republic Multipurpose Disinfectant Label with Hospital-Disinfectant Kill Claims, Opening the Door to Healthcare and Animal Care Markets GlobeNewswire · Aug 4, 2026 NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary Good Salt Life, Inc. Reports Strong Online Retail Growth in First Half of 2026 GlobeNewswire · Jul 15, 2026

Cash Flow (USD)

Metric20162017202320242025
Operating Cash Flow——$0——
Investing Cash Flow——$0——
Financing Cash Flow——$0——
Net Cash Flow——$0——
Free Cash Flow$0$0$0$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.16
EV / EBITDA-290.49
FCF Yield-0.00%
Quick Ratio0.36
Interest Coverage0.00
Return 1Y798.36%
Return 3Y1752.60%
Return 5Y—

Ownership

Insiders Held0.00%
Institutions Held0.00%
Institutions Float Held0.00%
Institutional HolderSharesReport Date
Captrust Financial Advisors502022-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAWHAscend Wellness Holdings, Inc. $0.39 -4.77% -0.60 $78.17M 0.00%
BRIBFBrii Biosciences Limited $0.13 +0.00% -2.71 $90.69M 0.00%
BXPHFBotanix Pharmaceuticals Limited $0.02 -30.23% -0.41 $29.89M 0.00%
HOFBFHofseth BioCare ASA $0.17 +0.00% -3.90 $68.47M 0.00%
IPHYFInnate Pharma S.A. $1.65 +0.00% -2.84 $154.94M 0.00%

About NDT Pharmaceuticals Inc.

NDT Pharmaceuticals Inc., a biotechnology firm situated in Vienna, Virginia, is dedicated to formulating a range of treatments for serious neurological ailments, particularly those stemming from traumatic brain injuries.

NDT Pharmaceuticals Inc. is headquartered in US.

NDT Pharmaceuticals Inc. (NDTP) stock trades at $0.55 with a market capitalization of $87.68M. The stock is valued at a price-to-earnings (P/E) ratio of -421.54, price-to-book of 2.72, price-to-sales of 716.71. Over the past 52 weeks the stock has ranged between $0.05 and $2.10, and currently trades 73.8% below its 52-week high.

On profitability, NDT Pharmaceuticals Inc. generates a return on equity (ROE) of -3.08%, return on capital employed of -0.75%, an operating margin of -248.67%, a net profit margin of -251.62%.

Official website: www.ndtpharma.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides